Researchers boost existing antibiotic to tackle drug resistance

12:05 EDT 4 Jul 2017 | Pharmafile

The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the problem is not given enough attention. New forecasts suggest that 10 million will die each year as a result of drug-resistant infections by 2050, highlighting the threat posed to global health. Now, a team from the University of Lincoln in the UK has developed a new form of antibiotic which has proven its ability to defeat existing multidrug-resistant infections.

read more

Original Article: Researchers boost existing antibiotic to tackle drug resistance


More From BioPortfolio on "Researchers boost existing antibiotic to tackle drug resistance"

Quick Search


Relevant Topics

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...